drugset
drugset / Trial / NCT04825340

To Explore a Bridging Index for the Effectiveness of the Clinical Trial

NCT04825340 ↗

Unknown 450 enrolled Changchun BCHT Biotechnology Co.
RandomizedParallel-groupSingle-blindPrevention

Summary

To explore a bridging index for the effectiveness of the clinical trial with Nasal Spray Lyophilized Live Attenuated Influenza Vaccine

Timeline

Start
2021-04-16
Primary completion
2022-03-25
Completion
2022-03-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Nasal Spray Lyophilized Live Attenuated Influenza Vaccine Vaccine 0.2 ml Intranasal

Indications

No indication recorded.